Patents by Inventor Dorothee Chabas

Dorothee Chabas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Osteopontin-related compositions and methods
    Patent number: 7282490
    Abstract: This invention provides a method for reducing the amount of osteopontin in an osteopontin-expressing cell comprising introducing into the cell a nucleic acid which specifically inhibits osteopontin expression in the cell. This invention also provides methods for inhibiting the onset of, and treating, osteopontin-related disorders, as well as compositions for practicing the same. This invention further provides methods for determining the amount of osteopontin in a sample, and a kit for practicing the same. This invention also provides methods for determining whether an agent reduces the amount of osteopontin in an osteopontin-expressing cell. Finally, this invention provides methods for treating a subject afflicted with a disorder mediated by an endogenous protein.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: October 16, 2007
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Dorothee Chabas, Lawrence Steinman
  • Osteopontin-related compositions and methods
    Publication number: 20050119204
    Abstract: This invention provides a method for reducing the amount of osteopontin in an osteopontin-expressing cell comprising introducing into the cell a nucleic acid which specifically inhibits osteopontin expression in the cell. This invention also provides methods for inhibiting the onset of, and treating, osteopontin-related disorders, as well as compositions for practicing the same. This invention further provides methods for determining the amount of osteopontin in a sample, and a kit for practicing the same. This invention also provides methods for determining whether an agent reduces the amount of osteopontin in an osteopontin-expressing cell. Finally, this invention provides methods for treating a subject afflicted with a disorder mediated by an endogenous protein.
    Type: Application
    Filed: November 21, 2002
    Publication date: June 2, 2005
    Inventors: Dorothee Chabas, Lawrence Steinman